We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
133 hedge funds and large institutions have $274M invested in Puma Biotechnology in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 36 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 36
10% more call options, than puts
Call options by funds: $6.83M | Put options by funds: $6.21M
8% less funds holding
Funds holding: 144 → 133 (-11)
13.54% less ownership
Funds ownership: 94% → 80.46% (-14%)
30% less capital invested
Capital invested by funds: $394M → $274M (-$119M)
33% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
133
Holders Change
-11
Holders Change %
-7.64%
% of All Funds
2.62%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
57
Reduced
36
Closed
27
Calls
$6.83M
Puts
$6.21M
Net Calls
+$624K
Net Calls Change
+$2.01M
Top Buyers
| 1 |
Millennium Management
New York
|
+$9.71M |
| 2 |
State Street
Boston,
Massachusetts
|
+$4.48M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.06M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.78M |
| 5 |
DM
Deerfield Management
New York
|
+$3.28M |
